Evidence map›Paper›PMID 40070704›Full record

ArticleOpen forum infectious diseases2024

Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and Infants.

Hannah G Davies, Mary Kyohere, Valerie Tusubira, Alexander Amone, Amusa Wamawobe, Cleophas Komugisha, Philippa Musoke, Lauren Hookham, Pooja Ravji, Melanie Etti and 10 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hannah G DaviesInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0002-9064-0874
Mary KyohereInstitute for Infection and Immunity, St George's, University of London, London, UK.
Valerie TusubiraMakerere University-Johns Hopkins University (MUJHU) Research Collaboration, Kampala, Uganda.ORCID https://orcid.org/0000-0002-3395-8755
Alexander AmoneMakerere University-Johns Hopkins University (MUJHU) Research Collaboration, Kampala, Uganda.ORCID https://orcid.org/0000-0001-5920-281X
Amusa WamawobeDepartment of Medical Microbiology, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0001-7503-6778
Cleophas KomugishaMakerere University-Johns Hopkins University (MUJHU) Research Collaboration, Kampala, Uganda.
Philippa MusokeMakerere University-Johns Hopkins University (MUJHU) Research Collaboration, Kampala, Uganda.
Lauren HookhamInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0001-9703-655X
Pooja RavjiDepartment of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Melanie EttiInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0002-3265-635X
Juliet Nsimire SendagalaMedical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
Dan R ShelleyCardiff University School of Medicine, Division of Infection & Immunity, Cardiff, UK.ORCID https://orcid.org/0009-0001-8195-1689
Caitlin FarleyCardiff University School of Medicine, Division of Infection & Immunity, Cardiff, UK.ORCID https://orcid.org/0009-0006-5309-2991
Merryn VoyseyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0001-6324-6559
Owen B SpillerCardiff University School of Medicine, Division of Infection & Immunity, Cardiff, UK.ORCID https://orcid.org/0000-0002-9117-6911
Joseph PeacockInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0002-8767-7377
Musa SekikuboDepartment of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0002-7335-9650
Paul T HeathInstitute for Infection and Immunity, St George's, University of London, London, UK.
Kirsty Le DoareInstitute for Infection and Immunity, St George's, University of London, London, UK.ORCID https://orcid.org/0000-0002-5104-085X
PROGRESS Study Author Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Epidemiological evidence about the etiology and antimicrobial resistance of neonatal infections remains limited in low-resource settings. We aimed to describe the etiology of neonatal infections in a prospective observational cohort study conducted at two hospital sites in Kampala, Uganda. Methods: Babies admitted to either unit with risk factors or signs of sepsis, pneumonia, or meningitis had a blood culture, nasopharyngeal swab, and lumbar puncture (if indicated) collected. Basic demographics were collected, and babies were followed up until discharge or death to determine admission outcome. Blood cultures were processed using the BACTEC system and identification confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Cerebrospinal fluid was processed using standard microbiological testing and swabs were processed using the multiplex real-time polymerase chain reaction assay. Antimicrobial susceptibilities of bacterial isolates to World Health Organization-recommended first-line antibiotics (ampicillin or benzylpenicillin and gentamicin) were assessed using e-tests. Results: A total of 7323 infants with signs or risk factors for sepsis had blood cultures, 2563 had nasopharyngeal swabs, and 23 had lumbar punctures collected. Eleven percent of blood cultures and 8.6% of swabs were positive. Inpatient mortality was 12.1%, with 27.7% case fatality observed among infants with Gram-negative bloodstream infections. Conclusions: Our study demonstrates high levels of antimicrobial resistance and inpatient mortality from neonatal sepsis in the first months of life in Uganda. This underscores the pressing need for revised, context-specific antimicrobial treatment guidelines that account for the evolving landscape of antimicrobial resistance in neonatal sepsis.

Indexed as

antimicrobial resistancebloodstream infectionsneonatal sepsisrespiratory infectionssurveillance

Identifiers

PMID40070704
PMCPMC11891137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.